Ultrasonographic Assessment of Gastric Residual Volume

Sponsor
Gurhan Taskin (Other)
Overall Status
Completed
CT.gov ID
NCT04413474
Collaborator
(none)
56
1
12.6
4.5

Study Details

Study Description

Brief Summary

A recent systematic review reported that the prevalence of enteral nutrition intolerance in critically ill patients ranged from 2% to 75%, and the pooled rate was 38.3%.Many randomized controlled trials have reported that the incidence of pneumonia, regurgitation and aspiration do not correlate well with gastric residual volume (GRV) monitoring. In addition, it was reported that GRV monitoring may cause more frequent obstructions in the enteral tube access, leading to greater loss of time for intensive care unit nurses and patients receiving less than the prescribed daily intake due to enteral nutrition interruptions. The most recent SCCM/ASPEN guidelines in 2016 recommended that GRV monitoring not be included in the daily care protocol, but many institutions still use it to determine whether to continue enteral nutrition or to detect enteral tube-feeding intolerance. This study aimed to evaluate the relationship between ultrasonographic gastric antral measurements and aspirated gastric residual volume GRV in mechanically ventilated critically ill patients receiving enteral tube feeding via nasogastric, orogastric, or percutaneous gastrostomy tubes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Data collection and measurements:

    The following clinical parameters of included patients will be recorded: age, sex, body weight, height, body mass index, Acute Physiology and Chronic Health Evaluation II (APACHE

    1. score on the day of admission,the Charlson Comorbidity Index score, any comorbid diseases, the total amount of EN product during the last 24 hours before ultrasonographic assessment, vasopressor therapy during imaging, and the dose of the vasopressors.
    Ultrasonographic gastric antrum imaging procedure:

    Ultrasonographic gastric antrum imaging will be carried out by the same intensivist on each patient just before routine tube-feed aspiration. Gastric antrum images will be obtained with a 2.5-6 MHz curvilinear probe placed in the sagittal plane of the epigastric region. All imaging attempts will be carried out in a 30-degree head-elevation supine position as described previously. Reference points will be used to obtain images of the gastric antrum-left anterior lobe of the liver, head of pancreas and abdominal aorta.The anteroposterior and craniocaudal diameters of the gastric antrum will be measured three times for each ultrasonographic assessment. The mean value of the three will be recorded. The universally accepted Two-Diameter Method defined by Bolondi et al. will be used for the measurement of antral cross-sectional area.

    Tube-feeding aspiration (GRV measurement) procedure:

    Routine gastric residual volume aspirations will be performed by the nursing staff blinded to the ultrasonographic measurements. The time between gastric antrum imaging and the beginning of GRV aspiration will be recorded in minutes. Gastric contents will slowly aspirated with 50 ml syringes for at least 10 minutes until stomach contents could no longer be aspirated. Patients will be reassessed with ultrasonography after the aspiration to ensure that the stomach is completely emptied with aspiration.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    56 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Does Ultrasonographic Assessment of Gastric Antrum Correlate With Gastric Residual Volume in Critically Ill Patients? A Prospective Study
    Actual Study Start Date :
    Jan 1, 2018
    Actual Primary Completion Date :
    Jan 19, 2019
    Actual Study Completion Date :
    Jan 19, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Study group

    Unselected critically ill patients who met the inclusion criteria

    Outcome Measures

    Primary Outcome Measures

    1. Correlation between antral cross-sectional area and enteral tube feeding volumes. [From date of inclusion until the date of enteral tube-feeding termination or until the date of weaning from mechanical ventilation or until the date of discharging from ICU or until the date of the death, whichever came first, assessed up to one month.]

      The correlation between aspirated tube-feeding volumes and ultrasonographic gastric antral cross-sectional area measurements in critically ill patients receiving enteral tube feeding.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years of age or older

    • Mechanically ventilated in the intensive care unit

    • Receiving enteral tube feeding via nasogastric, orogastric, or percutaneous gastrostomy tubes, and the tip of the enteral feeding-tube having been shown to be present in the stomach in a recent x-ray

    Exclusion Criteria:
    • Pregnancy

    • Intestinal obstruction, gastric perforation, known upper gastrointestinal anatomical problem (e.g., hiatal hernia, gastric cancer, etc.)

    • Food and liquid by mouth being withheld due to long-term fasting requirement for any medical reasons (e.g., gastrointestinal tract bleeding, etc.)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Health Sciences, Trabzon Kanuni Training and Research Hospital Trabzon Turkey 61250

    Sponsors and Collaborators

    • Gurhan Taskin

    Investigators

    • Principal Investigator: Gurhan Taskin, MD, Gulhane School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gurhan Taskin, Principal Investigator, Gulhane School of Medicine
    ClinicalTrials.gov Identifier:
    NCT04413474
    Other Study ID Numbers:
    • 2017/72
    First Posted:
    Jun 4, 2020
    Last Update Posted:
    Jun 17, 2020
    Last Verified:
    Jun 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Gurhan Taskin, Principal Investigator, Gulhane School of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 17, 2020